SCHEMBL5724955

SCHEMBL5724955

COc1ccc(NS(=O)(=O)c2c(C)cc(O)cc2C)c(N)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYTH2 Q99418 2/20 0.53
ALDH1A1 P00352 5/20 0.50
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
TSHR P16473 2/20 0.47
LMNA P02545 2/20 0.47
HTT P42858 2/20 0.47
FFAR4 Q5NUL3 1/20 0.45
HPGD P15428 2/20 0.44
SLC40A1 Q9NP59 2/20 0.43
GAA P10253 6/20 0.43
POLB P06746 3/20 0.43
GFER P55789 1/20 0.43
KEAP1 Q14145 1/20 0.42
MAPT P10636 3/20 0.42
KDM4E B2RXH2 2/20 0.42
THRB P10828 1/20 0.42
RECQL P46063 1/20 0.42
BLM P54132 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5724390 0.85 ALDH1A1 (0.46) CYTH2ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL5724386 0.83 ALDH1A1 (0.44) CYTH2ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL5378279 0.82 TSHR (0.54) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL14356231 0.82 MAPK1 (0.54) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL6511241 0.81 TDP1 (0.47) CYTH2ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL26906975 0.75 PTGS1 (0.48) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL5762543 0.75 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL32670745 0.72 SLC40A1 (0.43) ALDH1A1MEN1KMT2ASMN1; SMN2FFAR4
SCHEMBL5956173 0.70 FFAR4 (0.64) FFAR4KEAP1
SCHEMBL5368085 0.70 MAPK1 (0.60) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644352-A1 PROCESS FOR PREPARING ISOMERICALLY PURE PRODRUGS OF PROTON PUMP INHIBITORS Allergan, Inc. (US) 2006-04-12 EP disclosed
WO-2005016917-A1 PROCESS FOR PREPARING ISOMERICALLY PURE PRODRUGS OF PROTON PUMP INHIBITORS ALLERGAN, INC. (US) 2005-02-24 WO disclosed